Abivax (ABVX) EPS (Basic) (2022 - 2026)
Abivax's (ABVX) quarterly EPS (Basic) came in at -$0.72 in Q1 2026, up 17.32% year-on-year from -$0.61 in Q1 2025, and up 47.63% quarter-over-quarter from -$1.37 in Q4 2025.
Abivax (ABVX) EPS (Basic) (2022 - 2026) Analysis & Trends
Abivax's EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.72 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 17.32% year-over-year to -$0.72 in Q1 2026; TTM through Mar 2026 was -$4.89, a 55.38% decrease from a year earlier, with the FY2025 full-year figure at -$5.72, down 89.26% from the prior year.
- EPS (Basic) grew to -$0.72 in Q1 2026 per ABVX's latest filing, from -$1.37 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.66 in Q2 2024 and bottomed at -$3.46 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.87 (2025), against an average of -$1.45.
- Across the five-year window, EPS (Basic) soared 79.05% in 2024 and plunged 156.22% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$3.46 in 2022, then rose by 8.08% to -$3.18 in 2023, then jumped by 79.05% to -$0.67 in 2024, then tumbled by 105.81% to -$1.37 in 2025, then jumped by 47.63% to -$0.72 in 2026.
- Per Business Quant, the three latest ABVX EPS (Basic) figures stand at -$0.72 (Q1 2026), -$1.37 (Q4 2025), and -$2.46 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | -0.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.72 |
| Dec 31, 2025 | -1.37 |
| Sep 30, 2025 | -2.46 |
| Jun 30, 2025 | -0.86 |
| Mar 31, 2025 | -0.87 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | -0.96 |
| Jun 30, 2024 | -0.66 |
| Mar 31, 2024 | -0.74 |
| Dec 31, 2023 | -3.18 |
| Dec 31, 2022 | -3.46 |